Publications

• Corrigendum to "Downregulation of microRNA-206 promotes invasion and angiogenesis of triple negative breast cancer" [Biochem. Biophys. Res. Commun. 477 (3) (2016) 461-466].
  Biochem Biophys Res Commun Volume: 754 Page(s): 151508
  03/25/2025 Authors: Liang Z; Bian X; Shim H
• LPA5-Dependent signaling regulates regeneration of the intestinal epithelium following irradiation.
  Am J Physiol Gastrointest Liver Physiol Volume: 326 Page(s): G631 - G642
  06/01/2024 Authors: McConnell BB; Liang Z; Xu C; Han Y; Yun CC
• Corrigendum to "Synthesis and evaluation of 2,5-furan, 2,5-thiophene and 3,4-thiophene-based derivatives as CXCR4 inhibitors" [Eur. J. Med. Chem. 181 (2019) 111562].
  Eur J Med Chem Volume: 261 Page(s): 115753
  12/05/2023 Authors: Gaines T; Garcia F; Virani S; Liang Z; Yoon Y; Oum YH; Shim H; Mooring SR
• Editorial Expression of Concern: Regulation of miR-19 to Breast Cancer Chemoresistance Through Targeting PTEN.
  Pharm Res Volume: 39 Page(s): 3381
  12/01/2022 Authors: Liang Z; Li Y; Huang K; Wagar N; Shim H
• Retraction Note to: Inhibition of breast cancer metastasis with microRNA-302a by downregulation of CXCR4 expression.
  Breast Cancer Res Treat Volume: 196 Page(s): 665
  12/01/2022 Authors: Liang Z; Bian X; Shim H
• Compensatory Upregulation of LPA2 and Activation of the PI3K-Akt Pathway Prevent LPA5-Dependent Loss of Intestinal Epithelial Cells in Intestinal Organoids.
  Cells Volume: 11
  07/20/2022 Authors: Liang Z; Yun CC
• Retraction Note to: MicroRNA30cregulated HDAC9 mediates chemoresistance of breast cancer.
  Cancer Chemother Pharmacol Volume: 89 Page(s): 843
  06/01/2022 Authors: Liang Z; Feng A; Shim H
• Survival of Stem Cells and Progenitors in the Intestine Is Regulated by LPA5-Dependent Signaling.
  Cell Mol Gastroenterol Hepatol Volume: 14 Page(s): 129 - 150
  01/01/2022 Authors: Liang Z; He P; Han Y; Yun CC
• Discovery of novel aminopiperidinyl amide CXCR4 modulators through virtual screening and rational drug design.
  Eur J Med Chem Volume: 201 Page(s): 112479
  09/01/2020 Authors: Oum YH; Kell SA; Yoon Y; Liang Z; Burger P; Shim H
• MicroRNA-30c-regulated HDAC9 mediates chemoresistance of breast cancer.
  Cancer Chemother Pharmacol Volume: 85 Page(s): 413 - 423
  02/01/2020 Authors: Liang Z; Feng A; Shim H
• A benzenesulfonamide derivative as a novel PET radioligand for CXCR4.
  Bioorg Med Chem Volume: 28 Page(s): 115240
  01/15/2020 Authors: Oum YH; Shetty D; Yoon Y; Liang Z; Voll RJ; Goodman MM; Shim H
• Amide-sulfamide modulators as effective anti-tumor metastatic agents targeting CXCR4/CXCL12 axis.
  Eur J Med Chem Volume: 185 Page(s): 111823
  01/01/2020 Authors: Wu R; Yu W; Yao C; Liang Z; Yoon Y; Xie Y; Shim H; Bai R
• Synthesis and evaluation of 2,5-furan, 2,5-thiophene and 3,4-thiophene-based derivatives as CXCR4 inhibitors.
  Eur J Med Chem Volume: 181 Page(s): 111562
  11/01/2019 Authors: Gaines T; Garcia F; Virani S; Liang Z; Yoon Y; Oum YH; Shim H; Mooring SR
• Development of CXCR4 modulators based on the lead compound RB-108.
  Eur J Med Chem Volume: 173 Page(s): 32 - 43
  07/01/2019 Authors: Bai R; Jie X; Sun J; Liang Z; Yoon Y; Feng A; Oum Y; Yu W; Wu R; Sun B
• Assessing Treatment Response of Glioblastoma to an HDAC Inhibitor Using Whole-Brain Spectroscopic MRI.
  Tomography Volume: 5 Page(s): 53 - 60
  03/01/2019 Authors: Gurbani SS; Yoon Y; Weinberg BD; Salgado E; Press RH; Cordova JS; Ramesh KK; Liang Z; Velazquez Vega J; Voloschin A
• Synthesis and evaluation of 2,5-diamino and 2,5-dianilinomethyl pyridine analogues as potential CXCR4 antagonists.
  Bioorg Med Chem Lett Volume: 29 Page(s): 220 - 224
  01/15/2019 Authors: Virani S; Liang Z; Yoon Y; Shim H; Mooring SR
• HDAC9 overexpression confers invasive and angiogenic potential to triple negative breast cancer cells via modulating microRNA-206.
  Biochem Biophys Res Commun Volume: 503 Page(s): 1087 - 1091
  09/05/2018 Authors: Salgado E; Bian X; Feng A; Shim H; Liang Z
• Anti-inflammatory hybrids of secondary amines and amide-sulfamide derivatives.
  Eur J Med Chem Volume: 150 Page(s): 195 - 205
  04/25/2018 Authors: Bai R; Sun J; Liang Z; Yoon Y; Salgado E; Feng A; Oum Y; Xie Y; Shim H
• HDAC inhibitor suppresses proliferation and invasion of breast cancer cells through regulation of miR-200c targeting CRKL.
  Biochem Pharmacol Volume: 147 Page(s): 30 - 37
  01/01/2018 Authors: Bian X; Liang Z; Feng A; Salgado E; Shim H
• Novel anti-inflammatory agents targeting CXCR4: Design, synthesis, biological evaluation and preliminary pharmacokinetic study.
  Eur J Med Chem Volume: 136 Page(s): 360 - 371
  08/18/2017 Authors: Bai R; Liang Z; Yoon Y; Salgado E; Feng A; Gurbani S; Shim H
• Development of CXCR4 modulators by virtual HTS of a novel amide-sulfamide compound library.
  Eur J Med Chem Volume: 126 Page(s): 464 - 475
  01/27/2017 Authors: Bai R; Shi Q; Liang Z; Yoon Y; Han Y; Feng A; Liu S; Oum Y; Yun CC; Shim H
• Synthesis and evaluation of 2,5 and 2,6 pyridine-based CXCR4 inhibitors.
  Bioorg Med Chem Volume: 24 Page(s): 5052 - 5060
  11/01/2016 Authors: Gaines T; Camp D; Bai R; Liang Z; Yoon Y; Shim H; Mooring SR
• Downregulation of microRNA-206 promotes invasion and angiogenesis of triple negative breast cancer.
  Biochem Biophys Res Commun Volume: 477 Page(s): 461 - 466
  08/26/2016 Authors: Liang Z; Bian X; Shim H
• Symmetrical bis-tertiary amines as novel CXCR4 inhibitors.
  Eur J Med Chem Volume: 118 Page(s): 340 - 350
  08/08/2016 Authors: Bai R; Liang Z; Yoon Y; Liu S; Gaines T; Oum Y; Shi Q; Mooring SR; Shim H
• Whole-brain spectroscopic MRI biomarkers identify infiltrating margins in glioblastoma patients.
  Neuro Oncol Volume: 18 Page(s): 1180 - 1189
  08/01/2016 Authors: Cordova JS; Shu H-KG; Liang Z; Gurbani SS; Cooper LAD; Holder CA; Olson JJ; Kairdolf B; Schreibmann E; Neill SG
• A systematic pipeline for the objective comparison of whole-brain spectroscopic MRI with histology in biopsy specimens from grade III glioma.
  Tomography Volume: 2 Page(s): 106 - 116
  06/01/2016 Authors: Cordova JS; Gurbani SS; Olson JJ; Liang Z; Cooper LAD; Shu H-KG; Schreibmann E; Neill SG; Hadjipanayis CG; Holder CA
• USE OF VOLUMETRIC MR SPECTROSCOPIC IMAGING AND 5-ALA FLUORESCENCE-GUIDED SURGERY FOR RESECTION OF GLIOBLASTOMA
  Volume: 16
  11/01/2014 Authors: Cordova JS; Liang Z; Holder CA; Appin C; Schreibmann E; Bian X; Brat D; Shu H-K; Olson J; Maudsley A
• Inhibition of breast cancer metastasis with microRNA-302a by downregulation of CXCR4 expression.
  Breast Cancer Res Treat Volume: 146 Page(s): 535 - 542
  08/01/2014 Authors: Liang Z; Bian X; Shim H
• Synthesis of pyridine derivatives as potential antagonists of chemokine receptor type 4.
  Heterocycl Comm Volume: 20 Page(s): 149 - 153
  05/01/2014 Authors: Mooring SR; Gaines T; Liang Z; Shim H
• MicroRNA-302 replacement therapy sensitizes breast cancer cells to ionizing radiation.
  Pharm Res Volume: 30 Page(s): 1008 - 1016
  04/01/2013 Authors: Liang Z; Ahn J; Guo D; Votaw JR; Shim H
• Benzenesulfonamides: a unique class of chemokine receptor type 4 inhibitors.
  ChemMedChem Volume: 8 Page(s): 622 - 632
  04/01/2013 Authors: Mooring SR; Liu J; Liang Z; Ahn J; Hong S; Yoon Y; Snyder JP; Shim H
• Development of a unique small molecule modulator of CXCR4.
  PLoS One Volume: 7 Page(s): e34038
  01/01/2012 Authors: Liang Z; Zhan W; Zhu A; Yoon Y; Lin S; Sasaki M; Klapproth J-MA; Yang H; Grossniklaus HE; Xu J
• Regulation of miR-19 to breast cancer chemoresistance through targeting PTEN.
  Pharm Res Volume: 28 Page(s): 3091 - 3100
  12/01/2011 Authors: Liang Z; Li Y; Huang K; Wagar N; Shim H
• Potential Biomarker of L-type Amino Acid Transporter 1 in Breast Cancer Progression.
  Nucl Med Mol Imaging Volume: 45 Page(s): 93 - 102
  06/01/2011 Authors: Liang Z; Cho HT; Williams L; Zhu A; Liang K; Huang K; Wu H; Jiang C; Hong S; Crowe R
• Dipyrimidine amines: a novel class of chemokine receptor type 4 antagonists with high specificity.
  J Med Chem Volume: 53 Page(s): 8556 - 8568
  12/23/2010 Authors: Zhu A; Zhan W; Liang Z; Yoon Y; Yang H; Grossniklaus HE; Xu J; Rojas M; Lockwood M; Snyder JP
• Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1.
  Biochem Pharmacol Volume: 79 Page(s): 817 - 824
  03/15/2010 Authors: Liang Z; Wu H; Xia J; Li Y; Zhang Y; Huang K; Wagar N; Yoon Y; Cho HT; Scala S
• Blockade of invasion and metastasis of breast cancer cells via targeting CXCR4 with an artificial microRNA.
  Biochem Biophys Res Commun Volume: 363 Page(s): 542 - 546
  11/23/2007 Authors: Liang Z; Wu H; Reddy S; Zhu A; Wang S; Blevins D; Yoon Y; Zhang Y; Shim H
• Discovery of small molecule CXCR4 antagonists.
  J Med Chem Volume: 50 Page(s): 5655 - 5664
  11/15/2007 Authors: Zhan W; Liang Z; Zhu A; Kurtkaya S; Shim H; Snyder JP; Liotta DC
• CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway.
  Biochem Biophys Res Commun Volume: 359 Page(s): 716 - 722
  08/03/2007 Authors: Liang Z; Brooks J; Willard M; Liang K; Yoon Y; Kang S; Shim H
• CXC chemokine receptor-4 antagonist blocks both growth of primary tumor and metastasis of head and neck cancer in xenograft mouse models.
  Cancer Res Volume: 67 Page(s): 7518 - 7524
  08/01/2007 Authors: Yoon Y; Liang Z; Zhang X; Choe M; Zhu A; Cho HT; Shin DM; Goodman MM; Chen ZG; Shim H
• Antitumor effect of 2-methoxyestradiol in a rat orthotopic brain tumor model.
  Cancer Res Volume: 66 Page(s): 11991 - 11997
  12/15/2006 Authors: Kang S-H; Cho HT; Devi S; Zhang Z; Escuin D; Liang Z; Mao H; Brat DJ; Olson JJ; Simons JW
• Lower expression of CXCR4 in lymph node metastases than in primary breast cancers: potential regulation by ligand-dependent degradation and HIF-1alpha.
  Biochem Biophys Res Commun Volume: 346 Page(s): 252 - 258
  07/21/2006 Authors: Shim H; Lau SK; Devi S; Yoon Y; Cho HT; Liang Z
• Silencing of CXCR4 blocks breast cancer metastasis.
  Cancer Res Volume: 65 Page(s): 967 - 971
  02/01/2005 Authors: Liang Z; Yoon Y; Votaw J; Goodman MM; Williams L; Shim H
• Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4.
  Cancer Res Volume: 64 Page(s): 4302 - 4308
  06/15/2004 Authors: Liang Z; Wu T; Lou H; Yu X; Taichman RS; Lau SK; Nie S; Umbreit J; Shim H
• Genetic classification and differentiation of Bartonella species based on comparison of partial ftsZ gene sequences.
  J Clin Microbiol Volume: 40 Page(s): 3641 - 3647
  10/01/2002 Authors: Zeaiter Z; Liang Z; Raoult D
• Genotypic characteristics of two serotypes of Bartonella henselae.
  J Clin Microbiol Volume: 40 Page(s): 2002 - 2008
  06/01/2002 Authors: La Scola B; Liang Z; Zeaiter Z; Houpikian P; Grimont PAD; Raoult D
• Monoclonal antibodies to immunodominant epitope of Tropheryma whipplei.
  Clin Diagn Lab Immunol Volume: 9 Page(s): 156 - 159
  01/01/2002 Authors: Liang Z; La Scola B; Raoult D
• Immunofluorescent detection of intraerythrocytic Bartonella henselae in naturally infected cats.
  J Clin Microbiol Volume: 39 Page(s): 2978 - 2980
  08/01/2001 Authors: Rolain JM; La Scola B; Liang Z; Davoust B; Raoult D
• Production of Bartonella genus-specific monoclonal antibodies.
  Clin Diagn Lab Immunol Volume: 8 Page(s): 847 - 849
  07/01/2001 Authors: Liang Z; La Scola B; Lepidi H; Raoult D
• Differentiation of Bartonella species by a microimmunofluorescence assay, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and Western immunoblotting.
  Clin Diagn Lab Immunol Volume: 7 Page(s): 617 - 624
  07/01/2000 Authors: Liang Z; Raoult D
• Species-specific monoclonal antibodies for rapid identification of Bartonella quintana.
  Clin Diagn Lab Immunol Volume: 7 Page(s): 21 - 24
  01/01/2000 Authors: Liang Z; Raoult D